4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-032835
EVP, R&D & CMO gave up 4,630 shares (to pay taxes)
- EVP, R&D & CMO acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · EVP, R&D & CMO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-23 | Exercise or conversion : show line 1 in the form | +12,000 | 12,000 | D | ||
| 2019-05-24 | Shares withheld for taxes : show line 2 in the form | −4,630 | $119.31 | $552,405 | 7,370 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2019-05-23 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −12,000 | 12,000 | 0 | D |
Loading xslF345X03/doc4.xml…